Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.22 Billion DKK | -27.49% |
| 2022 | 16.85 Billion DKK | 3653.9% |
| 2021 | 449 Million DKK | 4.42% |
| 2020 | 430 Million DKK | 220.9% |
| 2019 | 134 Million DKK | 47.25% |
| 2018 | 91 Million DKK | -7.14% |
| 2017 | 98 Million DKK | -78.97% |
| 2016 | 466 Million DKK | 0.0% |
| 2015 | - DKK | 0.0% |
| 2014 | - DKK | -100.0% |
| 2013 | 7 Million DKK | 0.0% |
| 2012 | - DKK | -100.0% |
| 2011 | 1.99 Billion DKK | 0.0% |
| 2010 | - DKK | -100.0% |
| 2009 | 2.25 Billion DKK | -18.94% |
| 2008 | 2.78 Billion DKK | 17.33% |
| 2007 | 2.37 Billion DKK | -12.57% |
| 2006 | 2.71 Billion DKK | 57.18% |
| 2005 | 1.72 Billion DKK | 0.0% |
| 2004 | - DKK | -100.0% |
| 2003 | 2.04 Billion DKK | 26.8% |
| 2002 | 1.61 Billion DKK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 11.56 Billion DKK | 0.08% |
| 2024 Q1 | 12.2 Billion DKK | -0.04% |
| 2024 Q3 | 11.56 Billion DKK | -0.02% |
| 2023 Q3 | 17.06 Billion DKK | 0.12% |
| 2023 Q1 | 17.02 Billion DKK | 1.01% |
| 2023 FY | 12.22 Billion DKK | -27.49% |
| 2023 Q4 | 12.22 Billion DKK | -28.37% |
| 2023 Q2 | 17.04 Billion DKK | 0.1% |
| 2022 Q2 | 483 Million DKK | 12.33% |
| 2022 Q1 | 430 Million DKK | -4.23% |
| 2022 FY | 16.85 Billion DKK | 3653.9% |
| 2022 Q3 | 16.87 Billion DKK | 3394.0% |
| 2022 Q4 | 16.85 Billion DKK | -0.12% |
| 2021 Q1 | 471 Million DKK | 9.53% |
| 2021 FY | 449 Million DKK | 4.42% |
| 2021 Q4 | 449 Million DKK | 3.7% |
| 2021 Q3 | 433 Million DKK | -4.84% |
| 2021 Q2 | 455 Million DKK | -3.4% |
| 2020 Q4 | 430 Million DKK | 13.16% |
| 2020 Q1 | 418 Million DKK | 211.94% |
| 2020 Q2 | 402 Million DKK | -3.83% |
| 2020 Q3 | 380 Million DKK | -5.47% |
| 2020 FY | 430 Million DKK | 220.9% |
| 2019 Q1 | 92 Million DKK | 1.1% |
| 2019 FY | 134 Million DKK | 47.25% |
| 2019 Q3 | 84 Million DKK | -4.55% |
| 2019 Q4 | 134 Million DKK | 59.52% |
| 2019 Q2 | 88 Million DKK | -4.35% |
| 2018 Q3 | 97 Million DKK | -3.96% |
| 2018 Q1 | 325 Million DKK | 231.63% |
| 2018 Q4 | 91 Million DKK | -6.19% |
| 2018 Q2 | 101 Million DKK | -68.92% |
| 2018 FY | 91 Million DKK | -7.14% |
| 2017 Q3 | 228 Million DKK | -7.32% |
| 2017 Q2 | 246 Million DKK | -2.38% |
| 2017 Q1 | 252 Million DKK | -45.92% |
| 2017 Q4 | 98 Million DKK | -57.02% |
| 2017 FY | 98 Million DKK | -78.97% |
| 2016 Q4 | 466 Million DKK | 0.0% |
| 2016 Q2 | - DKK | 0.0% |
| 2016 FY | 466 Million DKK | 0.0% |
| 2016 Q3 | - DKK | 0.0% |
| 2016 Q1 | - DKK | 0.0% |
| 2015 FY | - DKK | 0.0% |
| 2015 Q2 | - DKK | 0.0% |
| 2015 Q1 | - DKK | 0.0% |
| 2015 Q3 | - DKK | 0.0% |
| 2015 Q4 | - DKK | 0.0% |
| 2014 Q2 | - DKK | 0.0% |
| 2014 Q4 | - DKK | 0.0% |
| 2014 FY | - DKK | -100.0% |
| 2014 Q1 | - DKK | -100.0% |
| 2014 Q3 | - DKK | 0.0% |
| 2013 Q3 | - DKK | 0.0% |
| 2013 FY | 7 Million DKK | 0.0% |
| 2013 Q4 | 7 Million DKK | 0.0% |
| 2013 Q2 | - DKK | 0.0% |
| 2013 Q1 | - DKK | 0.0% |
| 2012 Q3 | 792 Million DKK | -58.4% |
| 2012 Q4 | - DKK | -100.0% |
| 2012 FY | - DKK | -100.0% |
| 2012 Q1 | 1.93 Billion DKK | -2.91% |
| 2012 Q2 | 1.9 Billion DKK | -1.75% |
| 2011 Q3 | 1.93 Billion DKK | -0.72% |
| 2011 FY | 1.99 Billion DKK | 0.0% |
| 2011 Q1 | 2.02 Billion DKK | 0.0% |
| 2011 Q2 | 1.94 Billion DKK | -3.81% |
| 2011 Q4 | 1.99 Billion DKK | 3.37% |
| 2010 Q3 | 1.89 Billion DKK | 1.83% |
| 2010 Q4 | - DKK | -100.0% |
| 2010 FY | - DKK | -100.0% |
| 2010 Q2 | 1.85 Billion DKK | -7.65% |
| 2010 Q1 | 2.01 Billion DKK | -10.82% |
| 2009 FY | 2.25 Billion DKK | -18.94% |
| 2009 Q4 | 2.25 Billion DKK | 0.0% |
| 2008 FY | 2.78 Billion DKK | 17.33% |
| 2007 FY | 2.37 Billion DKK | -12.57% |
| 2006 FY | 2.71 Billion DKK | 57.18% |
| 2005 FY | 1.72 Billion DKK | 0.0% |
| 2004 FY | - DKK | -100.0% |
| 2003 FY | 2.04 Billion DKK | 26.8% |
| 2002 FY | 1.61 Billion DKK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -1632.935% |
| Ansell Limited | 706.6 Million USD | -1629.691% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -54434.349% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -1955420.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -897.578% |
| ConvaTec Group Plc | 1.22 Billion USD | -896.169% |
| Encision Inc. | 67.33 Thousand USD | -18150666.306% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -3192381.395% |
| LifePoint, Inc. | 151.73 Thousand USD | -8054785.523% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -248617.949% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -1987217.073% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -6791296.009% |
| SmileDirectClub, Inc. | 849.37 Million USD | -1338.934% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -5698.465% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -25205616.761% |
| Vasamed, Inc. | 18.95 Thousand USD | -64495942.216% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -66179237.232% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -3130174.43% |